Fund Holdings — New Leaf Venture Partners, L.L.C.

Total Portfolio Value:
$82.24M
Total Bought:
$97.6K
Total Sold:
$9.08M
Net Transaction:
-$8.98M
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Arvinas, Inc.(ARVN)1,289,5211,289,5210$53.23M$34.33M41.74%-$18.90M
Edgewise Therapeutics, Inc.(EWTX)1,553,6611,553,6610$28.34M$27.98M34.03%-$357.3K
Crinetics Pharmaceuticals Inc141,000141,0000$6.60M$6.32M7.68%-$284.8K
Rallybio Corporation(RLYB)3,301,6033,301,6030$6.11M$4.42M5.38%-$1.68M
Rocket Pharmaceuticals, Inc.(RCKT)118,242150,706+32,464$3.19M$3.24M3.95%+$59.3K
Cogent Biosciences, Inc.(COGT)250,765250,7650$1.69M$2.11M2.57%+$428.8K
Passage Bio, Inc.(PASG)2,497,9222,497,9220$3.37M$1.98M2.41%-$1.39M
Alector Inc339,569339,5690$2.04M$1.54M1.87%-$502.6K
X4 Pharmaceuticals, Inc.(XFOR)335,000335,0000$465.6K$194.3K0.24%-$271.4K
Iterum Therapeutics PlcSHS97,08497,086+2$149.5K$111.2K0.14%-$38.3K
Deciphera Pharmaceuticals Inc576,9750-576,975$9.08M$0—-$9.08M
Page 1 of 1
New Leaf Venture Partners, L.L.C. — 13F Holdings — Q2 2024 | TickerTrail